Regulation 33 of LODR Act 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Unjha Formulations Ltd, at its meeting on 4 February 2026, approved unaudited financial results for Q3 FY26 and the 9 months ended 31 December 2025. Net sales for the 9-month period stood at Rs 1,386.21 lakhs, up about 20.6% from Rs 1,149.65 lakhs in the same period last year. Profit after tax for 9M jumped to Rs 144.75 lakhs (EPS Rs 3.23) from Rs 81.21 lakhs (EPS Rs 1.81) a year earlier, an increase of around 78% YoY. For the standalone Q3 quarter, net sales fell to Rs 376.24 lakhs from Rs 428.53 lakhs YoY (about a 12% decline), though PAT edged up marginally to Rs 23.97 lakhs from Rs 22.40 lakhs. Statutory auditor Jain & Golechha issued a clean limited review report with no qualifications or emphasis of matter.
Strong 9M revenue and profit growth, driven by improving margins, is a positive signal for shareholders. However, the Q3 standalone revenue dip may temper near-term sentiment, even as profitability remains broadly stable.